- Home
- EDUC vs PHIO Comparison
EDUC vs PHIO Comparison
Compare EDUC & PHIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDUC
- PHIO
- Stock Information
- Founded
- EDUC 1965
- PHIO 2011
- Country
- EDUC United States
- PHIO United States
- Employees
- EDUC N/A
- PHIO N/A
- Industry
- EDUC Consumer Specialties
- PHIO Biotechnology: Pharmaceutical Preparations
- Sector
- EDUC Consumer Discretionary
- PHIO Health Care
- Exchange
- EDUC Nasdaq
- PHIO Nasdaq
- Market Cap
- EDUC 11.4M
- PHIO 12.1M
- IPO Year
- EDUC N/A
- PHIO N/A
- Fundamental
- Price
- EDUC $1.31
- PHIO $2.16
- Analyst Decision
- EDUC
- PHIO Strong Buy
- Analyst Count
- EDUC 0
- PHIO 3
- Target Price
- EDUC N/A
- PHIO $10.67
- AVG Volume (30 Days)
- EDUC 321.9K
- PHIO 140.9K
- Earning Date
- EDUC 10-09-2025
- PHIO 11-13-2025
- Dividend Yield
- EDUC N/A
- PHIO N/A
- EPS Growth
- EDUC N/A
- PHIO N/A
- EPS
- EDUC N/A
- PHIO N/A
- Revenue
- EDUC $31,304,000.00
- PHIO N/A
- Revenue This Year
- EDUC N/A
- PHIO N/A
- Revenue Next Year
- EDUC N/A
- PHIO N/A
- P/E Ratio
- EDUC N/A
- PHIO N/A
- Revenue Growth
- EDUC N/A
- PHIO N/A
- 52 Week Low
- EDUC $0.92
- PHIO $0.97
- 52 Week High
- EDUC $2.49
- PHIO $9.79
- Technical
- Relative Strength Index (RSI)
- EDUC 67.34
- PHIO 51.18
- Support Level
- EDUC $1.08
- PHIO N/A
- Resistance Level
- EDUC $1.16
- PHIO $2.57
- Average True Range (ATR)
- EDUC 0.07
- PHIO 0.13
- MACD
- EDUC 0.03
- PHIO -0.06
- Stochastic Oscillator
- EDUC 85.00
- PHIO 83.95
About EDUC Educational Development Corporation
Educational Development Corp is the United States trade publisher of the line of educational children's books produced in the United Kingdom. Its business activity functions with two reportable segments: PaperPie and Publishing. The Publishing Division segment markets its products to retail accounts, which include books, school supplies, toy and gift stores and museums, through commissioned sales representatives, trade and specialty wholesalers and an internal telesales group.
About PHIO Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.